Clinical Presentation and the Treatment of Glaucoma in Patients with a Facial Port-wine Stain
Mi-Jin KIM; Won-June LEE; Ki-Ho PARK; Tae-Woo KIM; Eun-Ji LEE; Young-Suk YU; Jin-Wook JEOUNG.
Journal of the Korean Ophthalmological Society
; : 1234-1241, 2017.
ArtÃculo en Ko | WPRIM | ID: wpr-74538
Documentos relacionados
Port-wine Birthmarks: Update on Diagnosis, Risk Assessment for Sturge-Weber Syndrome, and Management.
Efficacy and safety of 595-nm pulsed dye laser treating port wine stains in Vietnamese patients: analysis of 124 cases and optimal treatment regimens.
Clinical characteristics of infants with port-wine stain and glaucoma secondary to Sturge-Weber Syndrome.
Treatment Update of Port-Wine Stain.
Analysis of related factors affecting hemoporfin-mediated photodynamic therapy for port-wine stain: A retrospective study.
Does interval time between pulsed dye laser treatments for port-wine stains influence outcome? A systematic review and meta-analysis.
Hematoporphyrin monomethyl ether photodynamic therapy for the treatment of Sturge-Weber syndrome and large segmental facial port-wine stain.
[Sturge-Weber syndrome in port-wine stain patients: a retrospective study on the clinical features and screening strategy].
Complication rates and safety of pulsed dye laser treatment for port-wine stain: a systematic review and meta-analysis.
Can 595-nm Pulsed Dye Laser in Conjunction With an Optical Clearing Agent Improve the Treatment of Port-Wine Stains?